Exosome-Mediated Benefits of Cell Therapy in Mouse and Human Models of Duchenne Muscular Dystrophy

Stem Cell Reports

Volumn 10, Issue 3, 2018, Pages 942-955

  Aminzadeh, Mark A ^a   Rogers, Russell G ^a   Fournier, Mario ^a   Tobin, Rachel E ^a   Guan, Xuan ^b   Childers, Martin K ^b   Andres, Allen M ^a   Taylor, David J ^a   Ibrahim, Ahmed ^a   Ding, Xiangming ^c   Torrente, Angelo ^a   Goldhaber, Joshua M ^a   Lewis, Michael ^a   Gottlieb, Roberta A ^a   Victor, Ronald A ^a   Marbán, Eduardo ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cardiomyopathy; cardiosphere derived cells; dystrophin; exosomes; microRNA; muscular dystrophy

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; DYSTROPHIN; MALONALDEHYDE; MYOGENIN; SOMATOMEDIN C RECEPTOR; SYNAPTOTAGMIN I;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE CELL; CARDIAC STEM CELL; CELL THERAPY; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; EXERCISE; EXON SKIPPING; EXOSOME; FAST MUSCLE; FEMALE; HEART FUNCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INDUCED PLURIPOTENT STEM CELL; MOUSE; MUSCLE GROWTH; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RNA SEQUENCE; SKELETAL MUSCLE; SOLEUS MUSCLE; ANIMAL; ANIMAL MUSCULAR DYSTROPHY; BIOLOGICAL THERAPY; C57BL MOUSE; CARDIAC MUSCLE; DISEASE MODEL; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROCEDURES; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; DISEASE MODELS, ANIMAL; DYSTROPHIN; EXOSOMES; FEMALE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE; MYOCARDIUM; MYOCYTES, CARDIAC;

EID: 85042262071     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2018.01.023     Document Type: Article

References (48)

1. Advani, V.M., Dinman, J.D., Reprogramming the genetic code: the emerging role of ribosomal frameshifting in regulating cellular gene expression. Bioessays 38 (2016), 21–26.
2. Aminzadeh, M.A., Tobin, R., Smith, R., Marban, L., Marban, E., Heart-derived cell therapy for Duchenne cardiomyopathy: cardiosphere-derived cells and their exosomes improve function, restore mitochondrial integrity and reverse degenerative changes in the hearts of Mdx mice. Circ. Res., 115, 2014, e90.
3. Aminzadeh, M.A., Durvasula, P., Tobin, R., Guan, X., Andres, A., Taylor, D., Ibrahim, A., Sun, B., Torrente, A., Goldhaber, J., Exosome-mediated reversal of Duchenne cardiomyopathy. Circulation, 132, 2015, A16015.
4. Aminzadeh, M.A., Tseliou, E., Sun, B., Cheng, K., Malliaras, K., Makkar, R.R., Marbán, E., Therapeutic efficacy of cardiosphere-derived cells in a transgenic mouse model of non-ischaemic dilated cardiomyopathy. Eur. Heart J. 36 (2015), 751–762.
5. Ascheim, D., Jefferies, J.L., A randomized, open-label study of the safety and efficacy of multi-vessel intracoronary delivery of allogeneic cardiosphere-derived cells in patients with cardiomyopathy secondary to Duchenne muscular dystrophy. 2016 https://clinicaltrials.gov/ct2/show/NCT02485938.
6. Bao, J.L., Lin, L., MiR-155 and Mir-148a reduce cardiac injury by inhibiting NF-kappaB pathway during acute viral myocarditis. Eur. Rev. Med. Pharmacol. Sci. 18 (2014), 2349–2356.
7. Bentzinger, C.F., Wang, Y.X., Rudnicki, M.A., Building muscle: molecular regulation of myogenesis. Cold Spring Harb. Perspect. Biol., 4, 2012, a008342.
8. Burelle, Y., Khairallah, M., Ascah, A., Allen, B.G., Deschepper, C.F., Petrof, B.J., Des Rosiers, C., Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart. J. Mol. Cell. Cardiol. 48 (2010), 310–321.
9. Carlson, C.G., Samadi, A., Siegel, A., Chronic treatment with agents that stabilize cytosolic IκB-α enhances survival and improves resting membrane potential in MDX muscle fibers subjected to chronic passive stretch. Neurobiol. Dis. 20 (2005), 719–730.
10. Cheng, K., Malliaras, K., Li, T.-S., Sun, B., Houde, C., Galang, G., Smith, J., Matsushita, N., Marbán, E., Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion. Cell Transplant. 21 (2012), 1121–1135.
11. Chimenti, I., Smith, R.R., Li, T.S., Gerstenblith, G., Messina, E., Giacomello, A., Marbán, E., Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ. Res. 106 (2010), 971–980.
12. Clusin, W.T., Mechanisms of calcium transient and action potential alternans in cardiac cells and tissues. Am. J. Physiol. Heart Circ. Physiol. 294 (2008), H1–H10.
13. Davis, D.R., Zhang, Y., Smith, R.R., Cheng, K., Terrovitis, J., Malliaras, K., Li, T.S., White, A., Makkar, R., Marbán, E., Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue. PLoS One, 4, 2009, e7195.
14. Gallet, R., Dawkins, J., Valle, J., Simsolo, E., de Couto, G., Middleton, R., Tseliou, E., Luthringer, D., Kreke, M., Smith, R.R., et al. Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. Eur. Heart J. 38 (2017), 201–211.
15. Guan, X., Mack, D.L., Moreno, C.M., Strande, J.L., Mathieu, J., Shi, Y., Markert, C.D., Wang, Z., Liu, G., Lawlor, M.W., Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery. Stem Cell Res. 12 (2014), 467–480.
16. Ibrahim, A.G.-E., Cheng, K., Marbán, E., Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Reports 2 (2014), 606–619.
17. Jefferies, J., Byrne, B., Taylor, M., Lima, J., Smith, R.R., Maliaris, K., Fedor, B., Rudy, J., Pogoda, J., Marban, L., et al. Cardiosphere-derived cells for the treatment of Duchenne cardiomyopathy: results of the Halt cardiOmyopathy ProgrEssion [HOPE]-Duchenne Trial. Circulation, 136, 2017, e448.
18. Kegel, M., Capricor set to launch phase 2 trial of cell therapy CAP-1002 in advanced DMD patients. Muscular Dystrophy News Today, 2017 https://musculardystrophynews.com/2017/12/01/fda-clears-capricor-phase-2-trial-dmd-therapy-cap-1002/.
19. Lässer, C., Eldh, M., Lötvall, J., Isolation and characterization of RNA-containing exosomes. J. Vis. Exp., 2012, e3037.
20. Lee, S.-T., White, A.J., Matsushita, S., Malliaras, K., Steenbergen, C., Zhang, Y., Li, T.S., Terrovitis, J., Yee, K., Simsir, S., Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. J. Am. Coll. Cardiol. 57 (2011), 455–465.
21. Lee, Y., Andaloussi, S.E., Wood, M.J., Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum. Mol. Genet. 21 (2012), R125–R134.
22. Li, T.S., Cheng, K., Malliaras, K., Smith, R.R., Zhang, Y., Sun, B., Matsushita, N., Blusztajn, A., Terrovitis, J., Kusuoka, H., Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J. Am. Coll. Cardiol. 59 (2012), 942–953.
23. Li, T.S., Cheng, K., Lee, S.T., Matsushita, S., Davis, D., Malliaras, K., Zhang, Y., Matsushita, N., Smith, R.R., Marbán, E., Cardiospheres recapitulate a niche-like microenvironment rich in stemness and cell-matrix interactions, rationalizing their enhanced functional potency for myocardial repair. Stem Cells 28 (2010), 2088–2098.
24. Lötvall, J., Hill, A.F., Hochberg, F., Buzás, E.I., Di Vizio, D., Gardiner, C., Gho, Y.S., Kurochkin, I.V., Mathivanan, S., Quesenberry, P., et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J. Extracell. Vesicles, 3, 2014, 29613.
25. Love, D., Morris, G., Ellis, J., Fairbrother, U., Marsden, R., Bloomfield, J., Edwards, Y., Slater, C., Parry, D., Davies, K., Tissue distribution of the dystrophin-related gene product and expression in the mdx and dy mouse. Proc. Natl. Acad. Sci. USA 88 (1991), 3243–3247.
26. Makkar, R., Schatz, R., Traverse, J., Hamer, A., Beattie, K., Smith, R.R., Kivel, F., Marbán, L., Marbán, E., Henry, T.D., ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): the one year Phase I results. Circulation, 130, 2014, A20536.
27. Makkar, R.R., Smith, R.R., Cheng, K., Malliaras, K., Thomson, L.E., Berman, D., Czer, L.S., Marbán, L., Mendizabal, A., Johnston, P.V., Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379 (2012), 895–904.
28. Malliaras, K., Li, T.S., Luthringer, D., Terrovitis, J., Cheng, K., Chakravarty, T., Galang, G., Zhang, Y., Schoenhoff, F., Van Eyk, J., Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells. Circulation 125 (2012), 100–112.
29. Malliaras, K., Makkar, R.R., Smith, R.R., Cheng, K., Wu, E., Bonow, R.O., Marbán, L., Mendizabal, A., Cingolani, E., Johnston, P.V., Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). J. Am. Coll. Cardiol. 63 (2014), 110–122.
30. Marbán, E., The secret life of exosomes: what bees can teach us about next-generation therapeutics. J. Am. Coll. Cardiol. 71 (2018), 193–200.
31. Martin, D., Rojo, A.I., Salinas, M., Diaz, R., Gallardo, G., Alam, J., de Galarreta, C.M.R., Cuadrado, A., Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/AKT pathway and the NRF2 transcription factor in response to the antioxidant phytochemical carnosol. J. Biol. Chem. 279 (2004), 8919–8929.
32. Menazza, S., Blaauw, B., Tiepolo, T., Toniolo, L., Braghetta, P., Spolaore, B., Reggiani, C., Di Lisa, F., Bonaldo, P., Canton, M., Oxidative stress by monoamine oxidases is causally involved in myofiber damage in muscular dystrophy. Hum. Mol. Genet. 19 (2010), 4207–4215.
33. Nagaya, N., Kangawa, K., Itoh, T., Iwase, T., Murakami, S., Miyahara, Y., Fujii, T., Uematsu, M., Ohgushi, H., Yamagishi, M., Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112 (2005), 1128–1135.
34. Rogers, R.G., Fournier, M., Aminzadeh, M.A., Gouin, K., Sanchez, L., Marban, E., Abstract 16576: intravenous infusion of cardiosphere-derived cells and their exosomes improve dystrophin-deficient cardiomyopathy in mdx mice. Circulation, 136, 2017, A16576.
35. Schiaffino, S., Mammucari, C., Regulation of skeletal muscle growth by the IGF1-AKT/PKB pathway: insights from genetic models. Skelet. Muscle, 1, 2011, 1.
36. Shen, D., Cheng, K., Marbán, E., Dose-dependent functional benefit of human cardiosphere transplantation in mice with acute myocardial infarction. J. Cell. Mol. Med. 16 (2012), 2112–2116.
37. Shirokova, N., Niggli, E., Cardiac phenotype of Duchenne muscular dystrophy: insights from cellular studies. J. Mol. Cell. Cardiol. 58 (2013), 217–224.
38. Smith, R.R., Barile, L., Cho, H.C., Leppo, M.K., Hare, J.M., Messina, E., Giacomello, A., Abraham, M.R., Marbán, E., Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115 (2007), 896–908.
39. Tandon, A., Villa, C.R., Hor, K.N., Jefferies, J.L., Gao, Z., Towbin, J.A., Wong, B.L., Mazur, W., Fleck, R.J., Sticka, J.J., Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in Duchenne muscular dystrophy. J. Am. Heart Assoc., 4, 2015, e001338.
40. Tseliou, E., Pollan, S., Malliaras, K., Terrovitis, J., Sun, B., Galang, G., Marbán, L., Luthringer, D., Marbán, E., Allogeneic cardiospheres safely boost cardiac function and attenuate adverse remodeling after myocardial infarction in immunologically mismatched rat strains. J. Am. Coll. Cardiol. 61 (2013), 1108–1119.
41. van Putten, M., Hulsker, M., Young, C., Nadarajah, V.D., Heemskerk, H., van der Weerd, L., t Hoen, P.A., van Ommen, G.J., Aartsma-Rus, A.M., Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice. FASEB J. 27 (2013), 2484–2495.
42. Verhaert, D., Richards, K., Rafael-Fortney, J.A., Raman, S.V., Cardiac involvement in patients with muscular dystrophies magnetic resonance imaging phenotype and genotypic considerations. Circ. Cardiovasc. Imaging 4 (2011), 67–76.
43. Vyas, N., Dhawan, J., Exosomes: mobile platforms for targeted and synergistic signaling across cell boundaries. Cell. Mol. Life Sci. 74 (2016), 1567–1576.
44. Webber, J., Clayton, A., How pure are your vesicles?. J. Extracell. Vesicles, 2, 2013 19861.
45. Wehling-Henricks, M., Jordan, M.C., Gotoh, T., Grody, W.W., Roos, K.P., Tidball, J.G., Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy. PLoS One, 5, 2010, e10763.
46. White, A.J., Smith, R.R., Matsushita, S., Chakravarty, T., Czer, L.S., Burton, K., Schwarz, E.R., Davis, D.R., Wang, Q., Reinsmoen, N.L., Intrinsic cardiac origin of human cardiosphere-derived cells. Eur. Heart J. 34 (2013), 68–75.
47. Williams, I.A., Allen, D.G., The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice. Am. J. Physiol. Heart Circ. Physiol. 293 (2007), H1969–H1977.
48. Zabeo, D., Cvjetkovic, A., Lasser, C., Schorb, M., Lotvall, J., Hoog, J.L., Exosomes purified from a single cell type have diverse morphology and composition. bioRxiv, 2016, 10.1101/094045.